Fasching CL - Search Results

1

Analysis of the tumor suppressor activity of the K-rev-1 gene in human tumor cell lines.

Sato KY, Polakis PG, Haubruck H, Fasching CL, McCormick F, Stanbridge EJ. Sato KY, et al. Among authors: fasching cl. Cancer Res. 1994 Jan 15;54(2):552-9. Cancer Res. 1994. PMID: 8275494

2

Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells.

Bader SA, Fasching C, Brodeur GM, Stanbridge EJ. Bader SA, et al. Cell Growth Differ. 1991 May;2(5):245-55. Cell Growth Differ. 1991. PMID: 1679663

3

Chromosome 13 transfer provides evidence for regulation of RB1 protein expression.

Anderson MJ, Fasching CL, Xu HJ, Benedict WF, Stanbridge EJ. Anderson MJ, et al. Among authors: fasching cl. Genes Chromosomes Cancer. 1994 Apr;9(4):251-60. doi: 10.1002/gcc.2870090405. Genes Chromosomes Cancer. 1994. PMID: 7519047

4

Evidence that wild-type TP53, and not genes on either chromosome 1 or 11, controls the tumorigenic phenotype of the human fibrosarcoma HT1080.

Anderson MJ, Casey G, Fasching CL, Stanbridge EJ. Anderson MJ, et al. Among authors: fasching cl. Genes Chromosomes Cancer. 1994 Apr;9(4):266-81. doi: 10.1002/gcc.2870090407. Genes Chromosomes Cancer. 1994. PMID: 7519049

5

Loss of a putative tumor suppressor locus after gamma-ray-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.

Mendonca MS, Fasching CL, Srivatsan ES, Stanbridge EJ, Redpath JL. Mendonca MS, et al. Among authors: fasching cl. Radiat Res. 1995 Jul;143(1):34-44. Radiat Res. 1995. PMID: 7597142

6

Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells.

Plattner R, Anderson MJ, Sato KY, Fasching CL, Der CJ, Stanbridge EJ. Plattner R, et al. Among authors: fasching cl. Proc Natl Acad Sci U S A. 1996 Jun 25;93(13):6665-70. doi: 10.1073/pnas.93.13.6665. Proc Natl Acad Sci U S A. 1996. PMID: 8692875 Free PMC article.

7

Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.

Goyette MC, Cho K, Fasching CL, Levy DB, Kinzler KW, Paraskeva C, Vogelstein B, Stanbridge EJ. Goyette MC, et al. Among authors: fasching cl. Mol Cell Biol. 1992 Mar;12(3):1387-95. doi: 10.1128/mcb.12.3.1387-1395.1992. Mol Cell Biol. 1992. PMID: 1347643 Free PMC article.

8

Suppression of tumorigenicity in Wilms tumor by the p15.5-p14 region of chromosome 11.

Dowdy SF, Fasching CL, Araujo D, Lai KM, Livanos E, Weissman BE, Stanbridge EJ. Dowdy SF, et al. Among authors: fasching cl. Science. 1991 Oct 11;254(5029):293-5. doi: 10.1126/science.254.5029.293. Science. 1991. PMID: 1656527

9

Irradiation microcell-mediated chromosome transfer (XMMCT): the generation of specific chromosomal arm deletions.

Dowdy SF, Scanlon DJ, Fasching CL, Casey G, Stanbridge EJ. Dowdy SF, et al. Among authors: fasching cl. Genes Chromosomes Cancer. 1990 Nov;2(4):318-27. doi: 10.1002/gcc.2870020410. Genes Chromosomes Cancer. 1990. PMID: 2268580

10

Loss of suppressor loci on chromosomes 11 and 14 may be required for radiation-induced neoplastic transformation of HeLa x skin fibroblast human cell hybrids.

Mendonca MS, Howard K, Fasching CL, Farrington DL, Desmond LA, Stanbridge EJ, Redpath JL. Mendonca MS, et al. Among authors: fasching cl. Radiat Res. 1998 Mar;149(3):246-55. Radiat Res. 1998. PMID: 9496887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters